Unlocking the Promise of Genome Editing to DeliverĀ Life-Changing Medicines

Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

Read More


Latest News

February 8, 2016
Editas Medicine Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares Read More